An Observational Study For Ambrisentan

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Ambrisentan

Criteria

subjects who have been prescribed ambrisentan for a medically appropriate use (see approved product label)